Antimicrobial and anti-inflammatory treatment of bacterial meningitis. (Q33724683)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470558%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

review article

1 reference

title

Antimicrobial and anti-inflammatory treatment of bacterial meningitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470558%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470558%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

G H McCracken

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470558%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470558%20AND%20SRC:MED&resulttype=core&format=json

Infectious Disease Clinics of North America

12 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470558%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470558%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470558%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

619-36, vii

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470558%20AND%20SRC:MED&resulttype=core&format=json

Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Listeria and gram-negative bacillary meningitis in New York City, 1972-1979. Frequent causes of meningitis in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Antimicrobial Therapy of Experimental Group B Streptococcal Infection in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Spread of penicillinase-producing and transfer plasmids from the gonococcus to Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Vancomycin therapy failure in Listeria monocytogenes peritonitis in a patient on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Acute bacterial meningitis in adults. A review of 493 episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Dexamethasone treatment for bacterial meningitis in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Beneficial effects of dexamethasone in children with pneumococcal meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Dexamethasone therapy for bacterial meningitis: Better never than late?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Aztreonam in the treatment of gram-negative bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Trimethoprim-Sulfamethoxazole for Bacterial Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Imaging of leukocyte-endothelium interaction using in vivo confocal laser scanning microscopy during the early phase of experimental pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Evaluation of the antiinflammatory and phospholipase-inhibitory activity of calpactin II/lipocortin I.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Effect of interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor in animal models of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

The effect of interleukin-10 on meningeal inflammation in experimental bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Bacterial meningitis: pathogenesis, pathophysiology, and progress

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Treatment of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Fine structural localization of a blood-brain barrier to exogenous peroxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Ceftazidime vs. standard therapy for pediatric meningitis: therapeutic, pharmacologic and epidemiologic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Factors influencing the penetration and activity of antibiotics in experimental meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Response to Therapy in an Experimental Rabbit Model of Meningitis Due to Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Moxifloxacin in the therapy of experimental pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Factors Influencing the Therapy of Experimental Proteus mirabilis Meningitis in Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Antibacterial Activity of -Lactam Antibiotics in Experimental Meningitis Due to Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Bacterial meningitis: recent advances in pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Molecular mechanisms of inflammation in experimental pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Gram-negative enteric bacillary meningitis: a twenty-one-year experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Imipenem/cilastatin treatment of bacterial meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with high-dose ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970097-0

7 January 2021

10.1016/S0891-5520(05)70097-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470558%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference